EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas

Angela Elia, Alexandre Roux, Marco Demasi, Clément Debacker, Maïmiti Seneca, Edouard Dezamis, Gonzague De France, Bénédicte Trancart, Jun Muto, Catherine Oppenheim, Fabrice Chrétien, Marc Zanello und 1 weitere

Journal of Neuro-Oncology · 2026-03 · 177 (1)

DOI: 10.1007/s11060-026-05526-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 13.03.2026. Verfasst von Angela Elia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne 1, rue Cabanis, Paris Cedex 14, F-75014, France. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Return to Work, Seizures. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The optimal oncological management of adult patients with IDH-mutant CNS WHO grade 3 diffuse gliomas remains debated, particularly given the potential neurotoxic effects of adjuvant therapies on cognition and health-related quality-of-life. METHODS: We conducted a retrospective single-center cohort study including 87 consecutive patients with IDH-mutant CNS WHO grade 3 glioma who underwent awake craniotomy. Patients were stratified into a surgery only group (n = 23) or an adjuvant oncological group (radiotherapy with or without chemotherapy; n = 64). Neurocognitive outcomes, seizure control, and return-to-work rates were assessed. Voxel-wise lesion-symptom mapping was performed to identify associations between radiation dose distribution and postoperative neurocognitive performance. RESULTS: Patients who did not receive postoperative adjuvant therapy showed better language (100% vs. 73.4%, p = 0.005) and executive and social function (95.6% vs. 70.1%, p = 0.013) outcomes. Left-sided tumor location and adjuvant treatment were independent predictors of poorer language and executive and social function outcomes, while adjuvant therapy was the only independent predictor of impaired executive and social function recovery. Voxel-wise lesion-symptom mapping analyses revealed significant associations between radiation exposure of specific white matter tracts involved in language and executive and social networks and postoperative neurocognitive decline. Seizure control did not differ between groups. Patients managed with surgery alone had higher 6-month employment rates and returned to work earlier. CONCLUSION: In this cohort, adjuvant therapy was associated with preliminary worse neurocognitive outcomes and reduced return-to-work rates, potentially reflecting the impact of radiation exposure on brain connectivity preserved during awake surgery. For selected patients, a watch-and-wait strategy following maximal safe resection may help preserve mid-term neurocognitive functioning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaReturn to WorkSeizuresAdultFemaleHumansMaleMiddle AgedCognitionCombined Modality TherapyCraniotomyFollow-Up StudiesIsocitrate DehydrogenaseMutationNeoplasm GradingNeuropsychological TestsRetrospective StudiesWakefulness

Stichwörter der Autor:innen

Awake craniotomyDiffuse gliomaNeurocognitive outcomeNeurotoxicityRadiotherapy

Substanzen

IDH1 protein, humanIsocitrate Dehydrogenase

Autor:innen und Institutionen

  • Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne 1, rue Cabanis, Paris Cedex 14, F-75014, France.
  • Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, IMA-Brain, Paris, F-75014, France.
  • Department of Neurosurgery, Fujita Health University School of Medicine, Toyoake, Japan.
  • Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne 1, rue Cabanis, Paris Cedex 14, F-75014, France. johanpallud@hotmail.com.
  • Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, IMA-Brain, Paris, F-75014, France. johanpallud@hotmail.com.

Zitieren

APA

Elia, A., Roux, A., Demasi, M., Debacker, C., Seneca, M., Dezamis, E., De France, G., Trancart, B., Muto, J., Oppenheim, C., Chrétien, F., Zanello, M., & Pallud, J. (2026). Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas. Journal of Neuro-Oncology, 177(1). https://doi.org/10.1007/s11060-026-05526-2

Vancouver

Elia A, Roux A, Demasi M, Debacker C, Seneca M, Dezamis E, et al. Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas. Journal of Neuro-Oncology. 2026;177(1). doi:10.1007/s11060-026-05526-2

BibTeX
@article{Elia2026,
  author = {Elia, Angela and Roux, Alexandre and Demasi, Marco and Debacker, Clément and Seneca, Maïmiti and Dezamis, Edouard and De France, Gonzague and Trancart, Bénédicte and Muto, Jun and Oppenheim, Catherine and Chrétien, Fabrice and Zanello, Marc and Pallud, Johan},
  title = {Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas},
  journal = {Journal of Neuro-Oncology},
  year = {2026},
  volume = {177},
  number = {1},
  doi = {10.1007/s11060-026-05526-2}
}
Kostenlos starten →